Rockefeller Capital Management’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
Other funds holding MREO
6CM
NM
KCM
Rockefeller Capital Management's MREO Position: Q3 2026 in Review
Rockefeller Capital Management held its Mereo BioPharma (MREO) position steady in Q3 2026 at 2,000 shares worth $804. The position accounts for ﹤0.01% of the portfolio, ranked #4674.
Rockefeller Capital Management first reported a position in MREO in Q3 2019 and has held it in 19 quarters since. The position peaked at $4.12K in Q3 2025. 53 funds tracked by Wall St. Rank hold MREO as of Q3 2026.
- Rockefeller Capital Management held 2,000 shares of Mereo BioPharma worth $804 as of Q3 2026.
- Rockefeller Capital Management left its Mereo BioPharma share count unchanged in Q3 2026.
- Mereo BioPharma made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4674 holding.
- Rockefeller Capital Management first reported a position in Mereo BioPharma in Q3 2019 and has held it in 19 quarters since.
- Rockefeller Capital Management's Mereo BioPharma position peaked at $4.12K in Q3 2025.
- 53 funds tracked by Wall St. Rank held Mereo BioPharma as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.